Bausch & Lomb Corp
BLCO: XTSE (CAN)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
CAD 27.00 | Prflm | Ljxjkktd |
We Think 2024 Will Be a Year of Innovation and Growth for Bausch & Lomb
Business Strategy and Outlook
Bausch & Lomb is one of the largest vision care companies in the U.S. Bausch spun off from its former parent company, Bausch Health, in 2022 and it now operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals.